Rigel Pharmaceuticals Inc (NASDAQ:RIGL)
| 1.54 Delayed Data As of Aug 12 |  +0.14 / +10.00%Today’s Change | 0.64 Today|||52-Week Range 4.24 | -41.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 4.9M | 37.9M | 12.6M | 10.4M | |
| Cost of Goods Sold | 69.0K | 25.0K | 25.0K | 138.0K | ||
| Depreciation And Amortization | 159.0K | 163.0K | 164.0K | 173.0K | ||
| Operating Expenses | Gross Income | 4.6M | 37.7M | 12.4M | 10.1M | |
| General Expenses | 29.0M | 35.1M | 30.8M | 31.4M | ||
| Research And Development | 11.1M | 13.8M | 10.9M | 13.2M | ||
| Total Operating Expenses | 29.2M | 35.3M | 31.0M | 31.7M | ||
| Non-Operating Expenses | Operating Income | -24.4M | 2.5M | -18.4M | -21.3M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -23.8M | 3.2M | -17.6M | -20.6M | |
| Net Income | -23.8M | 3.2M | -17.6M | -20.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 166.5M | 166.7M | 167.2M | 167.2M | |
| Shares To Calculate EPS Diluted | 166.5M | 167.6M | 167.2M | 167.2M | ||
| Earnings Per Share | EPS | -$0.14 | $0.02 | -$0.11 | -$0.12 | |
| EPS Diluted | -$0.14 | $0.02 | -$0.11 | -$0.12 | ||
